Post-approval studies (Phase 4)Study completedNCT02176681
What this trial is testing
A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
Who this might be right for
Haemodialyzed, Type 2 Diabetes
University Hospital, Strasbourg, France 70